Mohamad Tabrizi
Directeur Général chez Azkarra Therapeutics, Inc.
Profil
Mohamad Tabrizi is a Senior Advisor at ShangPharma Innovation, Inc. and the Chief Executive & Financial Officer, Secretary at Azkarra Therapeutics, Inc. He previously worked as an Executive Director-Business Development at Nektar Therapeutics from 2007 to 2017.
He also held positions as a Senior Director-Investor Relations at Assertio Therapeutics, Inc. in 2007, a Director & Healthcare Investment Banking at Needham & Co. LLC from 2006 to 2007, and a Vice President-Healthcare Investment Banking at Royal Bank of Canada from 2000 to 2003.
Additionally, he served as a Board Member at Circle Pharma, Inc. from 2018 to 2020.
Mr. Tabrizi obtained a graduate degree from Stanford University, an undergraduate degree from the University of California, Davis, and an MBA from SC Johnson College of Business.
His current job(s) include Senior Advisor at ShangPharma Innovation, Inc. and Chief Executive & Financial Officer, Secretary at Azkarra Therapeutics, Inc.
Postes actifs de Mohamad Tabrizi
| Sociétés | Poste | Début |
|---|---|---|
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Directeur Financier/CFO | 01/01/2017 |
Azkarra Therapeutics, Inc.
 Azkarra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Azkarra Therapeutics, Inc. is a medical research and development company that specializes in providing oncology therapies based on DNA damage response. The company is based in South San Francisco, CA. Mohamad Tabrizi has been the CEO of the company since 2019. | Directeur Général | 01/03/2019 |
Anciens postes connus de Mohamad Tabrizi
| Sociétés | Poste | Fin |
|---|---|---|
Circle Pharma, Inc.
 Circle Pharma, Inc. BiotechnologyHealth Technology Circle Pharma, Inc. provides biotechnology services. The company was founded by Matthew P. Jacobson and Scott Lokey in June 2014 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | 01/03/2020 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/01/2017 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Public Communications Contact | 02/01/2007 |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Corporate Officer/Principal | 01/01/2007 |
| ROYAL BANK OF CANADA | Corporate Officer/Principal | 01/01/2003 |
Formation de Mohamad Tabrizi
| Stanford University | Graduate Degree |
| University of California, Davis | Undergraduate Degree |
| SC Johnson College of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| ROYAL BANK OF CANADA | Finance |
| Entreprise privées | 5 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Needham & Co. LLC
Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Finance |
Circle Pharma, Inc.
Circle Pharma, Inc. BiotechnologyHealth Technology Circle Pharma, Inc. provides biotechnology services. The company was founded by Matthew P. Jacobson and Scott Lokey in June 2014 and is headquartered in San Francisco, CA. | Health Technology |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Finance |
Azkarra Therapeutics, Inc.
Azkarra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Azkarra Therapeutics, Inc. is a medical research and development company that specializes in providing oncology therapies based on DNA damage response. The company is based in South San Francisco, CA. Mohamad Tabrizi has been the CEO of the company since 2019. | Commercial Services |